Duchenne gene carrier as cause of asymptomatic hyperckemia

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 2 B, 2008, Pages 425-427

  De Almeida, Diogo Fraxino ^b,c,d   Melo Jr , Aluisio Cláudio Mentor Couto ^b   De Bittencourt, Paulo Rogério M ^a  

^a Unidade de Neurol Clin S C Ltda   (Brazil)

^b HOSPITAL NOSSA SENHORA DAS GRAÇAS   (Brazil)

^c STATE UNIVERSITY OF MARINGÁ   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; DYSTROPHIN; ELECTROLYTE; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; ASYMPTOMATIC HYPERCKEMIA; BLOOD CELL COUNT; CARDIOLOGY; CASE REPORT; DUCHENNE MUSCULAR DYSTROPHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; ELECTROPHYSIOLOGY; ENZYME DEFECT; EXON; FAMILY; FEMALE; FEVER; FOLLOW UP; FREE THYROXINE INDEX; GENE; GENE DELETION; GENETIC ANALYSIS; GENETIC COUNSELING; HEALTH CENTER; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LABORATORY; MOTOR UNIT POTENTIAL; MUSCLE BIOPSY; MYOPATHY; MYOTONIA; NERVE CONDUCTION; PARENT; POLYMERASE CHAIN REACTION; PUBLICATION; SEDIMENTATION RATE; SOUTHERN BLOTTING;

EID: 47749146523     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000300032     Document Type: Article

References (15)

1. Reijneveld JC, Notermans NC, Linssen WHJP, Wokke JHJ. Benign prognosis in idiopathic hyperCKemia. Muscle & Nerve 2000;23:575-579.
2. Hoffman EP, Arahata K, Minetti C, Bonilla E, Rowland LP. Dystrophinopathy in isolated cases of myopathy in females. Neurology 1992;42:967-975.
3. Rowland LP, Willner J, DiMauro S, Miranda A. Approaches to the membrane theory of Duchenne muscular dystrophy. In Angelini C, Danieli GA, Fontanari D (Eds). Muscular dystrophy: advances and new trends. Amsterdam, Excerpta Medica, 1980:3-13.
4. Brewster LM, de Visser M. Persistent hyperCKemia: fourteen patients studied in retrospect. Acta Neurol Scand 1988;77:60-63.
5. Prelle A, Tancredi L, Sciacco M, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002;249:305-311.
6. Dabby R, Sadeh M, Herman O, et al. Asymptomatic or minimally symptomatic hyperCKemia: histopathologic correlation. IMAJ 2006;8:110-113.
7. Joy JL, Oh SJ. Asymptomatic hyperCKemia: an electrophysiologic and histopathologic study. Muscle & Nerve 1989;12:206-209.
8. Walker RH, Peters JJ, Jung HH, Danek A. Diagnostic evaluation of clinically normal subjects with chronic hyperCKemia. Neurology 2007;68:535-536.
9. Weglinski MR, Wedel DJ, Engel AG. Malignant hyperthermia testing in patients with persistently increased serum creatine kinase (CK) levels. Anesth Analg 1997;84:1038-1041.
10. Tachi N, Wakai S, Yutoh Y, Chiba S, Miura J. Asymptomatic hyperCKemia: detection of an isolated carrier of Duchenne muscular dystrophy. J Child Neurol 1990;5:351-353.
11. Oliveira ASB, Gabbai AA, Schmidt B, et al. Carrier detection of Duchenne and Becker muscular dystrophy using muscular dystrophin immunohistochemistry. Arq Neuropsiquiatr 1992;50:478-485.
12. Bonilla E, Schmidt B, Samitt CE, et al. Normal and dystrophin-deficient muscle fibers in carriers of the gene for Duchenne muscular dystrophy. Am J Pathol 1988;133:440-445.
13. Panigrahi I, Mitall B. Carrier detection and prenatal diagnosis in Duchenne/Becker muscular dystrophy. Indian Pediatr 2001;38:631-639.
14. Werneck LC, Scola RH, Maegawa GH, Werneck MC. Comparative analysis of PCR-deletion detection and immunohistochemistry in Brazilian Duchenne and Becker muscular dystrophy patients. Am J Med Genet 2001;103:115-120.
15. Hoogerwaard EM, Bakker E, Ippel PF, et al. Signs and symptoms of Duchenne muscular dystrophy and Becker muscular dystrophy among carriers in The Netherlands: a cohort study. Lancet 1999;353:2116-2119.